Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125845391 | 12584539 | 1 | I | 201605 | 20160715 | 20160722 | 20160722 | EXP | US-PFIZER INC-2016348525 | PFIZER | 28.00 | YR | F | Y | 69.85000 | KG | 20160722 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125845391 | 12584539 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | 20235 | 300 | MG | CAPSULE, HARD | TID | ||||||
| 125845391 | 12584539 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | 400 MG, 2X/DAY | 20235 | 400 | MG | CAPSULE, HARD | BID | ||||||
| 125845391 | 12584539 | 3 | C | KEPPRA | LEVETIRACETAM | 1 | Oral | 500 MG, 1X/DAY | 0 | 500 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125845391 | 12584539 | 1 | Seizure |
| 125845391 | 12584539 | 2 | Back pain |
| 125845391 | 12584539 | 3 | Seizure |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125845391 | 12584539 | OT |
| 125845391 | 12584539 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125845391 | 12584539 | Anxiety | |
| 125845391 | 12584539 | Back pain | |
| 125845391 | 12584539 | Blood urine present | |
| 125845391 | 12584539 | Condition aggravated | |
| 125845391 | 12584539 | Contusion | |
| 125845391 | 12584539 | Drug ineffective | |
| 125845391 | 12584539 | Dyskinesia | |
| 125845391 | 12584539 | Fall | |
| 125845391 | 12584539 | Feeling abnormal | |
| 125845391 | 12584539 | Haemoptysis | |
| 125845391 | 12584539 | Insomnia | |
| 125845391 | 12584539 | Loss of consciousness | |
| 125845391 | 12584539 | Migraine | |
| 125845391 | 12584539 | Mood swings | |
| 125845391 | 12584539 | Palpitations | |
| 125845391 | 12584539 | Poor quality drug administered | |
| 125845391 | 12584539 | Product quality issue | |
| 125845391 | 12584539 | Pyrexia | |
| 125845391 | 12584539 | Respiratory tract congestion | |
| 125845391 | 12584539 | Seizure | |
| 125845391 | 12584539 | Stress fracture | |
| 125845391 | 12584539 | Tremor | |
| 125845391 | 12584539 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125845391 | 12584539 | 1 | 2015 | 0 | ||
| 125845391 | 12584539 | 3 | 201604 | 0 |